MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Orthostatic hypotension in Parkinson’s disease

L. Dommershuijsen, A. Heshmatollah, P. Koudstaal, M. Ikram, M. Ikram (Rotterdam, Netherlands)

Meeting: MDS Virtual Congress 2020

Abstract Number: 711

Keywords: Autonomic dysfunction, Orthostatic hypotension(OH)

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: We aimed to identify whether orthostatic hypotension (OH) is a prodromal marker of Parkinson’s disease (PD) or a symptom of later disease.

Background: Many patients with PD experience OH symptoms during the course of their illness. Although OH has long been attributed to a more advanced stage of the disease, more recently studies suggested that OH is a prodromal marker of PD. However, these studies were performed in highly selected patient populations or were registry-based studies with different definitions of OH. The association between OH and PD in the general population has been limitedly studied so far.

Method: This study was embedded in the Rotterdam Study, a large prospective population-based cohort study in the Netherlands. We measured early OH (<1 minute), OH (<3 minutes), delayed OH (<5 minutes), symptomatic OH and neurogenic OH in 6,600 participants between 1989 and 1993. First, we determined the relation between prevalent PD and OH using logistic regression. Second, we followed PD-free participants for the occurrence of PD until January 1st, 2016 and studied the association between OH and the risk of PD using Cox proportional-hazards models. All models were adjusted for age and sex.

Results: The mean age (SD) of the study population was 69.1 (8.9) years and 59.3% were women. OH was present in 1,269 (19.9%) participants and 51 (0.8%) had PD at the time of OH measurement. Presence of PD was significantly associated with OH, symptomatic OH and both early and delayed OH (Table 1). The strongest association was found for symptomatic OH (OR 3.22, 95% CI: 1.30-7.97). Neurogenic OH was also associated with PD, although this association was not significant (OR 1.92, 95% CI: 0.97-3.79). After exclusion of participants with prevalent PD or without consent for follow-up, 6,053 individuals remained for the longitudinal analysis. During a mean follow-up of 14.6 years (7.6), 111 participants were diagnosed with incident PD. OH at baseline was not associated with an increased risk of PD (HR 0.98, 95% CI: 0.60-1.62) (Table 2). In addition, we found no association between neurogenic OH, early OH or delayed OH and the risk of PD.

Conclusion: We found an association between prevalent PD and OH, but we did not find an association between OH and the risk of PD. Our current data do not support the notion that OH is a prodromal marker of PD. Future population-based studies are warranted to replicate our findings.

[table1]
[table2]

Table 1

Table 2

To cite this abstract in AMA style:

L. Dommershuijsen, A. Heshmatollah, P. Koudstaal, M. Ikram, M. Ikram. Orthostatic hypotension in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/orthostatic-hypotension-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/orthostatic-hypotension-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley